PTC Therapeutics
PTCT
PTCT
180 hedge funds and large institutions have $3.13B invested in PTC Therapeutics in 2021 Q2 according to their latest regulatory filings, with 16 funds opening new positions, 84 increasing their positions, 49 reducing their positions, and 40 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
less ownership
Funds ownership: →
less capital invested
Capital invested by funds: $ → $
12% less funds holding
Funds holding: 205 → 180 (-25)
17% less funds holding in top 10
Funds holding in top 10: 6 → 5 (-1)
60% less first-time investments, than exits
New positions opened: 16 | Existing positions closed: 40
Holders
180
Holding in Top 10
5
Calls
$11.8M
Puts
$5.25M
Top Buyers
| 1 | +$29.4M | |
| 2 | +$25.4M | |
| 3 | +$18.4M | |
| 4 |
Bank of New York Mellon
New York
|
+$17.3M |
| 5 |
Vanguard Group
Malvern,
Pennsylvania
|
+$14.6M |
Top Sellers
| 1 | -$68.6M | |
| 2 | -$33.6M | |
| 3 | -$21.3M | |
| 4 |
Wellington Management Group
Boston,
Massachusetts
|
-$19.4M |
| 5 |
CS
Candriam SCA
Strassen, Luxembourg,
Luxembourg
|
-$13.8M |